Sustained Engraftment of Cryopreserved Human Bone Marrow CD34(+) Cells in Young Adult NSG Mice

被引:27
|
作者
Wiekmeijer, Anna-Sophia [1 ]
Pike-Overzet, Karin [1 ]
Brugman, Martijn H. [1 ]
Salvatori, Daniela C. F. [2 ]
Egeler, R. Maarten [3 ,4 ]
Bredius, Robbert G. M. [3 ]
Fibbe, Willem E. [1 ]
Staal, Frank J. T. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, L-03-035,POB 9600, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Cent Lab Anim Facil, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands
[4] Univ Toronto, Hosp Sick Children, Div Hematol Oncol, Toronto, ON, Canada
来源
BIORESEARCH OPEN ACCESS | 2014年 / 3卷 / 03期
关键词
human bone marrow; stem cells; xenograft model; thymus;
D O I
10.1089/biores.2014.0008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hematopoietic stem cells (HSCs) are defined by their ability to repopulate the bone marrow of myeloablative conditioned and/or (lethally) irradiated recipients. To study the repopulating potential of human HSCs, murine models have been developed that rely on the use of immunodeficient mice that allow engraftment of human cells. The NSG xenograft model has emerged as the current standard for this purpose allowing for engraftment and study of human T cells. Here, we describe adaptations to the original NSG xenograft model that can be readily implemented. These adaptations encompass use of adult mice instead of newborns and a short ex vivo culture. This protocol results in robust and reproducible high levels of lympho-myeloid engraftment. Immunization of recipient mice with relevant antigen resulted in specific antibody formation, showing that both T cells and B cells were functional. In addition, bone marrow cells from primary recipients exhibited repopulating ability following transplantation into secondary recipients. Similar results were obtained with cryopreserved human bone marrow samples, thus circumventing the need for fresh cells and allowing the use of patient derived bio-bank samples. Our findings have implications for use of this model in fundamental stem cell research, immunological studies in vivo and preclinical evaluations for HSC transplantation, expansion, and genetic modification.
引用
收藏
页码:110 / 116
页数:7
相关论文
共 50 条
  • [1] ENGRAFTMENT AFTER INFUSION OF CD34 ENRICHED MARROW-CELLS
    BENSINGER, WI
    BERENSON, RJ
    ANDREWS, RG
    BUCKNER, CD
    SPITZER, G
    GARCIALOPEZ, J
    BERNSTEIN, ID
    HANSEN, JA
    INTERNATIONAL JOURNAL OF CELL CLONING, 1992, 10 : 176 - 178
  • [2] Engraftment potential into NOD/SCID mice of CD34+ cells derived from human fetal liver as compared to fetal bone marrow
    Wilpshaar, J
    Noort, WA
    Kanhai, HHH
    Willemze, R
    Falkenburg, JHF
    HAEMATOLOGICA, 2001, 86 (10) : 1021 - 1028
  • [3] The characterization, molecular cloning, and expression of a novel hematopoietic cell antigen from CD34(+) human bone marrow cells
    Uchida, N
    Yang, Z
    Combs, J
    Pourquie, O
    Nguyen, M
    Ramanathan, R
    Fu, J
    Welply, A
    Chen, S
    Weddell, G
    Sharma, AK
    Leiby, KR
    Karagogeos, D
    Hill, B
    Humeau, L
    Stallcup, WB
    Hoffman, R
    Tsukamoto, AS
    Gearing, DP
    Peault, B
    BLOOD, 1997, 89 (08) : 2706 - 2716
  • [4] Circadian variations in clock gene expression of human bone marrow CD34+ cells
    Tsinkalovsky, Oleg
    Smaaland, Rune
    Rosenlund, Benedikte
    Sothern, Robert B.
    Hirt, Asle
    Steine, Solrun
    Badiee, Azadeh
    Abrahamsen, Jenny Foss
    Eiken, Hans Geir
    Laerum, Ole Didrik
    JOURNAL OF BIOLOGICAL RHYTHMS, 2007, 22 (02) : 140 - 150
  • [5] EXPRESSION OF NEUROTROPHINS AND THEIR RECEPTORS IN HUMAN CD34+ BONE MARROW CELLS
    Paczkowska, E.
    Piecyk, K.
    Luczkowska, K.
    Kotowski, M.
    Roginska, D.
    Pius-Sadowska, E.
    Oronowicz, K.
    Ostrowski, M.
    Machalinski, B.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2016, 67 (01): : 151 - 159
  • [6] HARVESTING, CHARACTERIZATION, AND CULTURE OF CD34(+) CELLS FROM HUMAN BONE-MARROW, PERIPHERAL-BLOOD, AND CORD-BLOOD
    VANEPPS, DE
    BENDER, J
    LEE, W
    SCHILLING, M
    SMITH, A
    SMITH, S
    UNVERZAGT, K
    LAW, P
    BURGESS, J
    BLOOD CELLS, 1994, 20 (2-3): : 411 - 423
  • [7] Effect of homoharringtonine on bone marrow CD34 plus CD117 plus cells in patients with chronic myelogenous leukemia
    Li, Yu-Feng
    Deng, Zhikui
    Din, Ban-He
    Zhu, Jian-Bin
    LEUKEMIA & LYMPHOMA, 2012, 53 (05) : 934 - 939
  • [8] Growth and differentiation of human dendritic cells from CD34(+) progenitors
    Szabolcs, P
    Ciocon, DH
    Moore, MAS
    Young, JW
    DENDRITIC CELLS IN FUNDAMENTAL AND CLINICAL IMMUNOLOGY, VOL 3, 1997, 417 : 15 - 19
  • [9] Human bone marrow CD34- cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells
    Zanjani, ED
    Almeida-Porada, G
    Livingston, AG
    Flake, AW
    Ogawa, M
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (04) : 353 - 360
  • [10] A Novel mAb against a Human CD34 Peptide Reacts with the Native Protein on CD34+ Cells
    Shams, Mahmood
    Jeddi-Tehrani, Mahmood
    Haghighat, Farzaneh Notash
    Bayat, Ali Ahmad
    Mahmoudian, Jafar
    Rezvani, Mohammad Reza
    IRANIAN JOURNAL OF IMMUNOLOGY, 2013, 10 (04) : 259 - 266